Health and Wellness Needs Reported to Influence Quality of Life in People with Relapsing-Remitting Multiple Sclerosis, a Qualitative Investigation
Background: Multiple sclerosis (MS) is a chronic progressive neurological disease diagnosed commonly between 20-50 years of age, with over...
Fatigue Evolution for Patients without Relapses on the Fsiq-RMS Symptoms Domain
Background: Multiple sclerosis (MS) is a chronic, demyelinating disease of the central nervous system that results in progressive and...
An Update on Participants in the Iconquerms Network.
Background: iConquerMS is a multiple sclerosis (MS) participant-powered research network (PPRN), dedicated to engaging people affected by...
The Influence of Tethered and Joint HCP and Patient Education on Clinical Practice Behavior, Patient Activation, and Empowerment
Background: Advances in disease-modifying therapies (DMT) for multiple sclerosis (MS) have left clinicians challenged to incorporate DMTs,...
Combinatorial Analysis of Plasma and DNA Methylation Biomarkers in African American Patients with Multiple Sclerosis
Background: African American patients are at increased risk of developing severe forms of multiple sclerosis and have been underrepresented...
Comparing Infection-Related Outcomes By Sex in Patients with Multiple Sclerosis and Matched Controls Using Administrative Claims Data
Background: Few population-level sex-based risk estimates of specific infections exist for US patients with multiple sclerosis (MS)....